The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...